Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2002 R33 PAR-99-102 CAPRIOLI, RICHARD M VANDERBILT UNIVERSITY MOLECULAR ANALYSIS OF CANCER--IMAGING MASS SPECTROMETRY Complete
2011 R33 RFA-CA-10-004 GREIS, KENNETH DONALD UNIVERSITY OF CINCINNATI VALIDATION OF MALDI-MS-BASED INHIBITOR SCREENING TECHNOLOGIES FOR CANCER TARGETS Complete
2022 R33 CA21-004 NORMAN, THOMAS MAXWELL SLOAN-KETTERING INST CAN RESEARCH Systematic characterization of cancer variants using single-cell functional genomics Active
1999 R33 PAR-98-067 DOVICHI, NORMAN J UNIVERSITY OF ALBERTA SINGLE CELL PROTEOME PROJECT--CANCER PROGNOSIS Complete
2001 R33 PAR-99-102 SMITH, RICHARD D BATTELLE PACIFIC NORTHWEST LABORATORIES HIGH THROUGHPUT FTICR FOR MOLECULAR ANALYSIS OF CANCER Complete
2020 R33 RFA-CA-19-020 RECHT, MICHAEL PALO ALTO RESEARCH CENTER High-Throughput Screening Platform for Cancer Drug Discovery Active
2000 R33 PAR-98-067 SINGER, ROBERT H YESHIVA UNIVERSITY FISH AND CHIPS--SINGLE CELL EXPRESSION OF CANCER GENES Complete
2002 R33 PAR-99-102 ALBERTSON, DONNA G UNIVERSITY OF CALIFORNIA SAN FRANCISCO AMPLICON PROFILING BY ARRAY CGH Complete
1999 R33 PAR-98-067 LIZARDI, PAUL M. YALE UNIVERSITY MESSENGER RNA PROFILING BY SINGLE MOLECULE COUNTING Complete
2001 R33 PAR-99-102 DAVIS, RONALD WAYNE STANFORD UNIVERSITY TARGET IDENTIFICATION VIA HAPLO INSUFFICIENCY PROFILING Complete
2020 R33 RFA-CA-19-020 LEVINSON, NICHOLAS MARK UNIVERSITY OF MINNESOTA Time-resolved FRET-based allostery sensors for any protein kinase drug target Active
2000 R33 PAR-98-067 TOLIAS, PETER P PUBLIC HEALTH RESEARCH INSTITUTE FUNCTIONAL CLONING OF DNA AND RNA BINDING PROTEINS Complete
2002 R33 PAR-99-102 ALLBRITTON, NANCY L UNIVERSITY OF CALIFORNIA IRVINE PROFILING RAS ACTIVATED SIGNAL TRANSDUCTION PATHWAYS Complete
1999 R33 PAR-98-067 CHALMERS, JEFFREY JOHN OHIO STATE UNIVERSITY RAPID RARE CANCER CELL ISOLATION FOR MOLECULAR DIAGNOSIS Complete
2001 R33 PAR-99-102 DABORA, SANDRA L BRIGHAM AND WOMEN'S HOSPITAL MUTANT ANALYSIS OF TSC1 & TSC2 IN TSC RELATED DISORDERS Complete
2020 R33 RFA-CA-19-020 CHEN, FEI BROAD INSTITUTE, INC. Clinical implementations of spatial transcriptomics in tumors Active
2000 R33 PAR-98-067 AEBERSOLD, RUEDI H. UNIVERSITY OF WASHINGTON ISOTOPE CODED AFFINITY TAGS FOR QUANTITATIVE PROTEOMICS Complete
2002 R33 PAR-99-102 ZHOU, PENGBO WEILL MEDICAL COLLEGE OF CORNELL UNIV PROTEIN KNOCKOUT TECHNOLOGY/MOLECULAR ANALYSIS OF CANCER Complete
2022 R33 CA21-004 DRAKE, RICHARD R MEDICAL UNIVERSITY OF SOUTH CAROLINA Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids Completed
1999 R33 PAR-98-067 MCCLELLAND, MICHAEL SIDNEY KIMMEL CANCER CENTER REDUCED COMPLEXITY CDNA PROBES Complete
2001 R33 PAR-99-102 WEIER, HEINZ-ULRICH G UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB SPECTRAL IMAGING FOR PHENOTYPE ANALYSIS OF CANCER CELLS Complete
2007 R21 RFA-CA-07-019 NILSEN-HAMILTON, MARIT IOWA STATE UNIVERSITY DRUGCARTS TO COMBAT DRUG RESISTANCE Complete
2010 R21 RFA-CA-09-008 CHILES, THOMAS C. BOSTON COLLEGE A NOVEL NANOCOAXIAL BIOSENSOR FOR DETECTION OF CANCER BIOMARKERS Complete
2014 R21 RFA-CA-13-001 LEVENSON, RICHARD M. UNIVERSITY OF CALIFORNIA AT DAVIS HIGHLY MULTIPLEXED ION-BEAM TISSUE RNA IN SITU IMAGING WITH SUB-MICRON RESOLUTION Complete
2017 R21 RFA-CA-16-001 LEVINSON, NICHOLAS MARK UNIVERSITY OF MINNESOTA A novel time-resolved fluorescence-based high-throughput screening technology for discovering allosteric kinase inhibitors Complete
2021 R21 RFA-CA-20-017 CHEN, KAI UNIVERSITY OF SOUTHERN CALIFORNIA Novel Bisphosphonate PET Probes for Myeloma Bone Disease Active
2001 R21 PAR-99-100 FARIS, GREGORY W SRI INTERNATIONAL UPCONVERTING CHELATES FOR CANCER DETECTION AND DIAGNOSIS Complete
2003 R21 PAR-01-106 SOPER, STEVEN ALLAN LOUISIANA STATE UNIV A&M COL BATON ROUGE MICROSAMPLING UNIT FOR CAPTURING LOW ABUNDANT CELLS Complete
2009 R21 RFA-CA-08-007 WATERMAN, MARIAN L UNIVERSITY OF CALIFORNIA-IRVINE LEF-1 TRANSLATION IN CHRONIC MYELEGENOUS LEUKEMIA Complete
2013 R21 RFA-CA-13-001 LEVY, MATTHEW ALBERT EINSTEIN COLLEGE OF MEDICINE LECTIMERS: GLYCAN-ANCHORED SCAFFOLD LIBRARIES FOR TARGETING CARBOHYDRATE-BINDING Complete
2016 R21 RFA-CA-15-004 VANDER GRIEND, DONALD JAMES UNIVERSITY OF CHICAGO SUPRAMOLECULAR MATRIX MATERIALS FOR PROSTATE CANCER CELL BIOLOGY Complete
2006 R21 RFA-CA-06-002 WELSH, JOHN T SIDNEY KIMMEL CANCER CENTER CANCER VERTICAL ARRAYS Complete
2019 R21 RFA-CA-18-002 GARBER, MANUEL UNIV OF MASSACHUSETTS MED SCH WORCESTER A modular; customizable sequencing system for simultaneous genotyping and transcript analysis in single cells Active
2000 R21 PAR-98-067 HADDAD, BASSEM R GEORGETOWN UNIVERSITY CYTOGENETIC SCREENING OF MAMMARY EPITHELIAL CELLS Complete
2002 R21 PAR-99-100 WELSH, JOHN T SIDNEY KIMMEL CANCER CENTER VERTICAL COVERAGE ARRAYS IN ANALYZING TRANSCRIPTION Complete
2005 R21 RFA-CA-05-002 BOGDANOV, ALEXEI A UNIV OF MASSACHUSETTS MED SCH WORCESTER TRANSCRIPTION FACTOR REPORTER TECHNOLOGY Complete
2008 R21 RFA-CA-07-033 MUDDIMAN, DAVID C. NORTH CAROLINA STATE UNIVERSITY RALEIGH IMPROVED CANCER BIOMARKER DETECTION USING NOVEL AIR AMPLIFIER DESIGNS IN ESI-MS Complete
2011 R21 RFA-CA-10-003 HARISMENDY, OLIVIER UNIVERSITY OF CALIFORNIA SAN DIEGO IDENTIFICATION OF SOMATIC MUTATIONS IN RARE SUBCLONES OF SOLID TUMORS Complete
2015 R21 RFA-CA-14-003 ANDERSON, KAREN SUE ARIZONA STATE UNIVERSITY-TEMPE CAMPUS SINGLE CELL TECHNOLOGIES FOR RAPID DETECTION OF TUMOR HETEROGENEITY Complete
2018 R21 RFA-CA-17-010 SMITH, LLOYD M UNIVERSITY OF WISCONSIN-MADISON Novel NeuCode Tagging Reagents for Identification and Quantification of Intact Proteoforms in Cancer Tissues NCE
2022 R21 CA21-003 ARMITAGE, BRUCE A CARNEGIE-MELLON UNIVERSITY Fluorescent gammaPNA Miniprobes for Imaging Telomeric RNA Completed
2007 R21 RFA-CA-07-019 ANDERSON, KAREN S YALE UNIVERSITY UNIVERSAL TECHNOLOGY FOR PROFILING THE DYNAMICS OF NORMAL & ONCOGENIC SIGNALING Complete
2010 R21 RFA-CA-09-008 HAKANSSON, KRISTINA UNIVERSITY OF MICHIGAN NOVEL APPROACHES FOR STRUCTURAL DETERMINATION OF CANCER STEM CELL GLYCANS Complete
2014 R21 RFA-CA-13-003 WHITE, KEVIN P. UNIVERSITY OF CHICAGO MICRO-WESTERN ARRAY METHODOLOGY FOR ASSESSMENT OF PREANALYTICAL VARIABILITY IN BI Complete
2017 R21 RFA-CA-16-003 NECHAEV, SERGEI UNIVERSITY OF NORTH DAKOTA Transcriptome profiling of highly degraded specimens through global analysis of short RNA fragments. NCE
2001 R21 PAR-99-102 PARKOS, CHARLES A EMORY UNIVERSITY PHAGE DISPLAY AND PROSTATE NEOPLASIA PROGRESSION Complete
2009 R21 RFA-CA-08-007 ZENG, GANG UNIVERSITY OF CALIFORNIA LOS ANGELES AUTO-ANTIBODY PLUS PSA ASSAY FOR PATIENTS WITH PROSTATE CANCER Complete
2013 R21 RFA-CA-13-001 OZERS, MARY SZATKOWSKI PROTEOVISTA, LLC HIGH DENSITY PEPTIDE ARRAYS FOR CANCER-RELATED POST-TRANSLATIONAL MODIFICATIONS Complete
2020 R21 RFA-CA-19-021 SEIBEL, ERIC J UNIVERSITY OF WASHINGTON Rapid Needle Biopsy Assessment at Point of Care to advance personalized cancer therapy Active
2006 R21 RFA-CA-06-002 PORTEUS, MATTHEW H UNIVERSITY OF TEXAS SW MED CTR DEVELOPMENT OF GENE TARGETING IN C. ELEGANS AND D. RERIO USING ZINC FINGER Complete

Pages